Oncology Medical News about human chondrosarcoma

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Honokiol induces cell apoptosis in human chondrosarcoma cells through mitochondrial dysfunction and endoplasmic reticulum stress
Cancer Letters, 11/05/09

Chen Y–J et al. – Transfection of cells with GRP78 or calpain siRNA reduced honokiol–mediated cell apoptosis in JJ012 cells. Importantly, animal studies have revealed a dramatic 53% reduction in tumor volume after 21days of treatment. This study demonstrates that honokiol may be a novel anti–cancer agent targeting chondrosarcoma cells.

<< Previous
The emerging role of the distal Fallopian tube and p53 in pelvic...

Next >>
Reduced frequency of regulatory T cells in peripheral blood stem...

Involvement of AdipoR receptor in adiponectin-induced motility and alpha2beta1 integrin upregulation in human chondrosarcoma cells
Carcinogenesis, 10/08/09 Relevance Score: 67%

Correlation between MMP-13 and HDAC7 expression in human knee osteoarthritis
Modern Rheumatology, 10/05/09 Relevance Score: 66%

Overexpression of A disintegrin and metalloproteinase 28 is correlated with high histologic grade in conventional chondrosarcoma
Human Pathology, 11/12/09 Relevance Score: 45%

Development of genetically engineered human sperm immunocontraceptives
Journal of Reproductive Immunology, 10/28/09 Relevance Score: 45%

The influence of human rights on district nurse practice
British Journal of Community Nursing, 10/08/09 Relevance Score: 45%